Advertisement

Topics

Companies Related to "Biotech News Recap NASH Readout Coming CymaBay Therapeutics" [Most Relevant Company Matches] RSS

19:58 EDT 26th June 2019 | BioPortfolio

Here are the most relevant search results for "Biotech News Recap NASH Readout Coming CymaBay Therapeutics" found in our extensive corporate database of over 50,000 company records.

Showing "Biotech News Recap NASH Readout Coming CymaBay Therapeutics" Companies 1–25 of 3,500+

Extremely Relevant

Jecure Therapeutics Inc.

Jecure Therapeutics is focused on the discovery of novel therapeutics for the treatment of NASH and liver fibrosis. Jecure’s scientific founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician scientist in hepatology. With operations in the biotech hub of San Diego, California, Jecure combin...


Jecure Therapeutics

Jecure is focused on the discovery of novel therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure’s scientific founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician scientist in hepatology. With operations in the biotech hub of San Diego, Califo...

Recombinant Capital

Recombinant Capital (Recap) is a San Francisco Bay Area-based consulting firm specializing in biotechnology alliances, earned alliance revenues, product sales, employment agreements, company information and capitalization. Recap was founded in 1988 by Mark Edwards. Prior to founding Recap, Mr. Edwards was manager of business development at Chiron. Mr. Edwards has a bachelor's degree in economics a...


Relevant

Nash Finch Company

Patricia Nash

The quintessential embodiment of style, form and function, Patricia Nash Designs creates handbags and accessories that are made of beautiful, vegetable tanned Italian leather. The company was founded in 2012 by the designer Patricia Nash who was inspired by her extensive international travels and vintage handbags found in her mother’s closet. The coll...

EIN News

EIN News is a pioneering innovator of proprietary news technology. Combining both intelligent search technologies and the human element, EIN News stands above the rest as the most efficient, yet personalized, news service available anywhere. Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become th...

BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH Patent News, summaries of recently issued US patents, descriptions of biotechnology available for license, and recent commentary and reviews by biotechology legal professionals. BIOTECH Patent Report...

ConSynance Therapeutics Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments for NASH, the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. www.consynance.com

North American Specialty Hospital

Headquartered in Denver, NASH is a US majority-owned and managed enterprise. Incorporating US physicians in its service delivery, NASH is designed to provide pre-operative and post-operative services throughout the US, while providing clinical care in Cancun. http://northamericanspecialtyhospital.com/

Akarna Therapeutics Ltd.

Akarna Therapeutics is a privately held biopharmaceutical company developing novel small molecule therapeutics that target inflammatory and fibrotic diseases for which there is no approved treatment. Akarna’s lead program is a potential best-in-class FXR agonist for the treatment of non-alcoholic steatohepatitis (NASH). Akarna’s lead candidate is ...

Highline Therapeutics

Highline Therapeutics is a biotech incubator established by Versant Ventures in New York City. Modeled on Blueline Bioscience in Toronto, Highline aims to identify and accelerate translational research and biotech company formation. Highline will partner with both local academic institutions and pharmaceutical companies to help bridge the gap between acade...

Targeted Oncology

TargetedOnc.com provides the latest news and insight on next-generation therapeutics and their molecular targets for practicing oncologists. As the field of oncology continues to trend toward systemic biology and molecular aberrations, the challenge facing many oncologists is staying up-to-date with the future of cancer therapeutics. As such, TargetedOnc s...

Targeted Oncology™

TargetedOnc.com provides the latest news and insight on next-generation therapeutics and their molecular targets for practicing oncologists. As the field of oncology continues to trend toward systemic biology and molecular aberrations, the challenge facing many oncologists is staying up-to-date with the future of cancer therapeutics. As such, TargetedOnc s...

HARVEY NASH GROUP

Harvey Nash was founded in London in 1988. David Higgins, the current Executive Vice Chairman, was one of the original founders and still has a sizeable financial stake in the company. Early on, the management broadened the Group’s geographical coverage and increased the range of services, recognising the value this would add to the business in the longer term. An IPO in April 1997 facilitated a...

Gain Therapeutics SA

Gain Therapeutics is a preclinical stage biotech company developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx® technology. The company has several discovery programs in lysosomal storage diseases and CNS indications at various stages of dev...

U.S. News Media Group

The U.S. News Media Group is a multi-platform digital publisher of news and analysis, which includes the monthly U.S. News & World Report magazine, the digital-only U.S. News Weekly magazine, www.usnews.com, and www.rankingsandreviews.com. Focusing on Health, Money & Business, Education, and Public Service/Opinion, the U.S. News Media Group has earned a reputation as the leading provider of servic...

Viventia Biotech Inc.

Viventia Biotech Inc. is a leader in developing innovative therapeutics based upon the human immune response to cancer. Through its Hybridomics™ discovery platform and ImmunoMine™ screening technology, the Company is focused on developing "Totally Human" monoclonal antibodies either as targeted therapeutics, Armed Antibodies™, or as direct treatments to fight multiple forms of cancer.

ConSynance Therapeutics, Inc.

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. The company’s pipeline includes innovative treatments for nonalcoholic steatohepatitis (NASH), the orphan disease Prader-Willi syndrome, and irritable bowel syndrome. ConSynance are collaborating with Chengdu SciMount Pharmatech Co., Ltd., a drug discov...

Pharmacy Times and U.S. News & World Report

U.S. News & World Report is a multi-platform publisher of news and analysis, which includes the digital-only U.S. News Weekly magazine, www.usnews.com, and www.rankingsandreviews.com. Focusing on Health, Personal Finance, Education, Travel, Cars, and Public Service/Opinion, U.S. News has earned a reputation as the leading provider of service news an...

Laboratorytalk

Laboratorytalk is a news and information website aimed at Scientists and Laboratory Personnel throughout the world. We publish news releases, case studies and technical articles from any manufacturer which submits them to us (see below), making Laboratorytalk one of the most comprehensive news resources on the web. We currently have 15134 news releases from 1460 suppliers on the website. Laborator...

Reuters Health Information

Reuters Health (RH) is the world's leading provider of medical and healthcare news. Our news services are internationally recognized as unbiased, authoritative, timely and dependable, with the reputation for quality that one expects from a Reuters company. RH's news stories are written by a staff of dedicated journalists with a deep and broad knowledge of the healthcare field. From news bureaus in...

ECI Biotech

ECI Biotech is an early stage protein sensor company with strong intellectual property of particular value for diagnostic sensors and therapeutics. Founded in 1998, its technologies relate to the detection of microbial pathogens and stabilizing active proteins to protect against infection

BIBA Research

BIBA Research is the market research division of BIBA Medical Ltd, the UK-based leading provider of consulting and market analysis services for the medical device industry. BIBA Medical runs 5 newspapers (Vascular News, Cardiovascular News, Spinal News, Interventional News and Cardiac Rhythm News) and a separate conference organizing business branch.

Medical News Today

Medical News Today is the largest independent health and medical news website on the Internet. Medical News Today is updated with more than 50 articles every day, 7 days a week - more than any other health news site. The site is divided into 89 medical categories/specialities allowing you to browse only the news relevant you. Advanced news archive searches allow you to quickly find the articles yo...

Inversago Pharma Inc.

A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome (PWS), type 1 diabetes (T1D), obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH). Inversago’s techno...


More From BioPortfolio on "Biotech News Recap NASH Readout Coming CymaBay Therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks